Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Cellectis (CLLS) Reports Q3 Loss of $0.36/Share
November 22, 2016 5:03 PM ESTCellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.36), versus ($0.36) reported last year. Revenue for the quarter came in at $9.98 million, versus $11.31 million reported last year.
For earnings history and earnings-related data on Cellectis (CLLS) click here.
... More